Craft

Neuronasal

Neuronasal Summary

Company Summary

Overview
Neuronasal is a company that develops pharmacologic treatments for concussion (mild traumatic brain injury, mTBI). Its nose-to-brain drug delivery technology helps to bypass the blood-brain barrier and get drug to the brain along both the olfactory and trigeminal nerves.
Type
Private
Status
Active
Website
https://neuronasal.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Joe Hulihan

    Joe Hulihan, Chief Medical Officer

    • Thomas I. Bradshaw

      Thomas I. Bradshaw, President & CEO

      • Michael Kaufman

        Michael Kaufman, Vice President, Business Development & Commercialization.

        • Douglas A. Greene

          Douglas A. Greene, Head of Research

          Footer menu